Dual therapy with Glycopyrronium and Indacaterol versus monotherapy with Glycopyrronium in treatment of Copd patients

Hospital de Clínicas da Universidade Federal do Paraná0 个研究点开始时间: 2018年10月4日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients (men and women) with COPD confirmed by spirometry. The diagnosis of the disease will be made by performing spirometry that will confirm the obstruction to the airflow through the result of the relation between forced expiratory volume in the first second (FEV1) and forced vital capacity of less than seventy per cent after use of inhaled bronchodilator. The patient must have stable disease. No need for hospitalization in the thirty days prior to the evaluation. Preserved neurocognitive functions. Be an adult and agree to participate in the study.

•Patients with respiratory tract infection or who have been hospitalized for an exacerbation in the last month.

发起方

Hospital de Clínicas da Universidade Federal do Paraná